본문으로 건너뛰기
← 뒤로

Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review.

증례연속 1/5 보강
Internal medicine (Tokyo, Japan) 2025 Vol.64(22) p. 3244-3251
Retraction 확인
출처

Sekiguchi K, Motoo I, Ando T, Noguchi A, Fukuda R, Nomura K, Nakayama Y, Kajiura S, Ueda Y, Goto Y, Shimada S, Takashima Y, Takahashi S, Fujinami H, Yasuda I

📝 환자 설명용 한 줄

Screening for colorectal cancer (CRC) in individuals with Li-Fraumeni syndrome (LFS) typically recommends initiating colonoscopy at 25 years old.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Sekiguchi K, Motoo I, et al. (2025). Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review.. Internal medicine (Tokyo, Japan), 64(22), 3244-3251. https://doi.org/10.2169/internalmedicine.4945-24
MLA Sekiguchi K, et al.. "Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review.." Internal medicine (Tokyo, Japan), vol. 64, no. 22, 2025, pp. 3244-3251.
PMID 40222933

Abstract

Screening for colorectal cancer (CRC) in individuals with Li-Fraumeni syndrome (LFS) typically recommends initiating colonoscopy at 25 years old. We herein report a case of LFS with dual CRC and liver metastasis diagnosed before the recommended screening age. A 17-year-old boy with a history of sarcoma underwent colonoscopy, revealing 2 advanced CRCs: neuroendocrine carcinoma in the descending colon and adenocarcinoma in the rectum, each displaying distinct histological features. In addition, a TP53 missense mutation (p.His193Arg) was detected by a detailed genetic examination. LFS is associated with a heightened risk of rapid progression to invasive carcinomas due to TP53 variants. Therefore, earlier initiation of colonoscopy screening may be necessary for patients with LFS.

MeSH Terms

Humans; Li-Fraumeni Syndrome; Male; Adolescent; Colorectal Neoplasms; Colonoscopy; Tumor Suppressor Protein p53; Adenocarcinoma; Age of Onset; Mutation, Missense; Liver Neoplasms; Carcinoma, Neuroendocrine